Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Lilly

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lilly's 2013 sales performance.

Lilly

Gilead continues its exec clear-out, licenses antivirals from Novartis

Gilead continues its exec clear-out, licenses antivirals from Novartis Another big recruitment this month was that of Christi Shaw, poached from Eli Lilly to take on a new CEO role and cell therapy division Kite.

Kisqali combination follows Verzenio onto Cancer Drugs Fund

Kisqali combination follows Verzenio onto Cancer Drugs Fund The ruling is good news for the company, which is vying with two other treatments in the same CDK4/6 inhibitors class, Eli Lilly’s Verzenio and market leader, Pfizer’s ... Ibrance and Kisqali gained NICE approval for first line treatment of hormone

AbbVie’s Skyrizi gets rapid ‘yes’ from NICE

AbbVie’s Skyrizi gets rapid ‘yes’ from NICE It says that if patients and clinicians consider Skyrizi to be one of a range of suitable treatments, including Skyrizi, Cosentyx (secukinumab) and Eli Lilly’s Talz (ixekizumab), then the least

Amgen and Novartis abandon Alzheimer’s drug after worsening symptoms

Amgen and Novartis abandon Alzheimer’s drug after worsening symptoms Janssen and Lilly reporting similar patterns in earlier failed BACE inhibitor candidates.

BioNTech raises €290m for mRNA cancer vaccine platform

BioNTech raises €290m for mRNA cancer vaccine platform The Mainz-based company – which specialises in drugs and vaccines based on messenger RNA (mRNA) and already has a string of big pharma partners including Pfizer, Sanofi, Roche, Eli Lilly and

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics